Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis
AssigneeFerring B.V.
InventorsMaria Empar Chenoll Cuadros, Beatriz Casinos Ramo, Angela Silva Angulo, Daniel Ramon Vidal, Salvador Genoves Martinez
Life of this patent
Estimating the term…
Abstract
A novel lactic acid Lactobacillus rhamnosus bacterium suitable for treatment of e.g. bacterial vaginosis.
Claims20
A composition comprising lactic acid Lactobacillus rhamnosus bacteria of the strain BPL005 deposited at Colección Española de Cultivos Tipo (CECT) under accession number CECT 8800, wherein the concentration of viable bacterial cells of the strain in the composition is from 104 to 1014 colony forming units (cfu) per gram of the composition, wherein the composition comprises the bacteria in a frozen form, dried form or freeze-dried form.
A composition comprising lactic acid Lactobacillus rhamnosus bacteria of the strain BPL005 deposited at Colección Española de Cultivos Tipo (CECT) under accession number CECT 8800, wherein the concentration of viable bacterial cells of the strain in the composition is from 104 to 1014 colony forming units (cfu) per gram of the composition, wherein the composition also comprises a cryoprotectant.
A method of treating a disorder in a woman, comprising administering to a woman in need thereof an amount of a composition comprising lactic acid Lactobacillus rhamnosus bacteria of the strain BPL005 deposited at Colección Española de Cultivos Tipo (CECT) under accession number CECT 8800 effective to treat said disorder, wherein the disorder is imbalance of naturally occurring vaginal bacterial microbiota, vaginal infection, female genital infection, urogenital infection or urinary tract infection.
Dependencies are inferred from the claim text.